Evidence map›Paper›PMID 30736736›Full record

ArticleBMC microbiology2019

Osteopontin in the host response to Leishmania amazonensis.

Emilie Giraud, Eline Rouault, Laurence Fiette, Jean-Hervé Colle, Despoina Smirlis, Evie Melanitou

Open access · goldAbstract read
In one paragraph

Article in BMC microbiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Deciphering Host-Parasite Interplay inACS infectious diseases · 2024
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Emilie GiraudImmunophysiology and Parasitism Laboratory and Department of Parasites and Insect Vectors, Institut Pasteur, 28 rue du Dr Roux, 75724, Paris Cedex 15, France.
Eline RouaultImmunophysiology and Parasitism Laboratory and Department of Parasites and Insect Vectors, Institut Pasteur, 28 rue du Dr Roux, 75724, Paris Cedex 15, France.
Laurence FietteHuman Histopathology and animal models Laboratory, Institut Pasteur, 28 rue du Dr Roux, 75724, Paris Cedex 15, France.
Jean-Hervé ColleNuclear Magnetic Resonance of Biomolecules unit, Institut Pasteur, 28 rue du Dr Roux, 75724, Paris Cedex 15, France.
Despoina SmirlisMolecular Parasitology Laboratory, Microbiology Department, Hellenic Pasteur Institute, 127 Bas. Sofias Avenue, 11521, Athens, Greece.
Evie MelanitouImmunophysiology and Parasitism Laboratory and Department of Parasites and Insect Vectors, Institut Pasteur, 28 rue du Dr Roux, 75724, Paris Cedex 15, France. evie.melanitou@pasteur.fr.ORCID 0000-0002-2972-4788
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRPasteur Hellenic Institute · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLeishmania (L.) spp are intracellular eukaryotic parasites responsible for cutaneous or visceral leishmaniasis, replicating predominantly in macrophages (MF). In C57BL/6 mice virulence with L. amazonensis has been associated with inhibition of Th1 immune responses and an uncontrolled lesion development, whereas DBA/2 mice control any lesion. Parasitic clearance by the MFs requires the activation of proper immune responses. One of the immune related genes expressed in immune cells including MF, codes for osteopontin (OPN). OPN is a secreted glycoprotein, acting as an immune regulator. Its implication in promoting Th1 immunity in response to infectious microorganisms and its known protective effect against viral and bacterial infections via activation of the immune response, render OPN a molecule of interest in the study of the host response to L. amazonensis.

resultsWe examined the host response to L. amazonensis of opn mutant and wild type C57BL/6 mice. Bone marrow derived MFs were infected with the parasites in vitro, and opn mutant and wild type mice were inoculated in vivo by intradermal injection in the ears. The DBA/2 strain known to control L. amazonensis infection was also used for comparison. Our data indicate that the parasites increased opn gene expression and OPN protein while parasitic proliferation was contained in the presence of OPN. In the presence of parasites the expression of inflammation-related transcripts was inhibited. Interleukin-1-beta (IL-1β), and transcripts of the NLR-family (NLRC4, NLRP3) were down regulated after L. amazonensis infection. In the absence of OPN, the inhibition by the parasites of IL-1β transcripts was less efficient and a pyroptosis-like cell phenotype was detected in vitro, suggesting a central role of OPN in the host-response to L. amazonensis. Similarly, in vivo, in the absence of OPN, while the clinical inflammatory phenotype is more severe, an increase of these transcripts was observed.

conclusionsL. amazonensis infection induces opn gene expression and protein, which in turn participates in shaping the host response to the parasites, seemingly by decreasing the activation of inflammation. OPN, further evaluated as a target for Leishmaniasis control represents an additional interest in improving vaccination strategies against the parasites.

Indexed as

AnimalsFemaleHost-Parasite InteractionsInflammationInterferon-gammaInterleukin-1betaLeishmania braziliensisLeishmaniasis, VisceralMacrophagesMiceMice, Inbred C57BLMice, Inbred DBAOsteopontinTh1 CellsIL1B protein, mouseInterferon-gammaInterleukin-1betaOsteopontinSpp1 protein, mouseC57BL/6 miceInflammasomeInflammationLeishmania amazonensisMacrophageOsteopontinParasitesPyroptosis

Identifiers

PMID30736736
PMCPMC6368773
OpenAlexW2915009032

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.